Hamartomatous polyps are benign tumoral lesions that are characterized by disorganized o v e r g r o w t h o f n o r m a l t i s s u e s 1, 2 . T h e hamartomatous polyposis syndromes are a heterogeneous group of disorders including juvenile polyposis syndrome, PTEN hamartoma tumor syndromes; Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS) and Proteus syndrome, Peutz-Jeghers syndrome, multiple endocrine neoplasia syndrome 2B, hereditary mixed polyposis syndrome, Cronkhite-Canada syndrome, basal cell nevus syndrome and neurofibromatosis type I 2,3 .
B a n n a y a n -R i l e y -Ru v a l c a b a s y n d r o m e (OMIM#153480) is an autosomal dominant inherited hamartomatous polyposis syndrome. The terminology of 'BRRS' was firstly expressed in 1992 to describe three phenotypically similar but previously different denominated syndromes 3, 4 . Hallmark manifestations of BRRS are macrocephaly, developmental delay or intellectual disability, subcutaneous and visceral lipomatosis, hemangiomatosis, gastrointestinal polyposis and pigmented macules on glans penis/genitalia [3] [4] [5] . Herein, a patient with gastrointestinal polyposis who had a genetically confirmed diagnosis of BRRS is presented.
Case Report
A 6 -y e a r-o l d b o y, b o r n f r o m a n o nconsanguineous marriage, was referred to our hospital with complaints of hematochezia and abdominal pain that began nearly 18 months ago. His past medical history showed that he had got a diagnosis of epilepsy 3 years ago and he remained in remission with sodium valproate. He has been both medication and seizure-free for nearly a year. He was macrosomic at birth (4,000 g at term) but no complication occurred during perinatal period. He had developmental delay; he achieved head control at 10 months of age, he could sit without support at 18 months of age, and he was able to walk and talk after 2 years of age and at 4.5 years of age, respectively. He was operated for pes equinovarus deformity when he was 1-year-old. His family history was unremarkable.
On physical examination, weight was 18 kg (25 th percentile), height was 109 cm (25 th percentile) and head circumference was 55 cm (>97 th percentile). He had macrocephaly with a prominent and high forehead, hypertelorism, low-set and small ears, micrognathia and high-arched palate, widely-spaced and inverted nipples, café au lait spots on trunk, hyperpigmented macular lesions on glans penis hyperextensible joints, enlarged halluces and thumbs with convex nails, kyphosis, and sandal gap on dysmorphological examination (Fig. 1) . Oral mucosa and tongue were normal and he had no trichilemmomas and other cutaneous hamartomas. Denver developmental screening test proved motor and language development delay.
Esophagogastroduodenoscopy and colonoscopy were performed to find out a cause for hematochezia. Three polyps in the 2nd part of the duodenum and two polyps in the stomach were seen at upper endoscopy, however, colonoscopy revealed innumerable, multilobulated, ulcerated and hemorrhagic polyps with a diameter of 1 to 4 cm throughout the colon and terminal ileum (Fig. 2) . Some parts of the colon lumen were markedly narrowed because of huge polyps. Histological assessment of colonic and duodenal polyps was consistent with juvenile polyps. Barium study supported the presence of duodenal and jejunal polyps.
DNA analysis was performed for BannayanRiley-Ruvalcaba syndrome, as suggested by intestinal juvenile polyposis and accompanying dysmorphic features. Sequence analysis of all exons of phosphatase and tensine homologue (PTEN) gene and multiplex ligation-dependent probe amplification (MLPA) revealed a heterozygous de novo complete deletion of PTEN gene, confirming the clinical diagnosis.
Multiplex ligation-dependent probe amplification was carried out according to the manufacturer's instructions with the P225 PTEN kit (MRC, Holland®). The MLPA PCR products were separated by electrophoresis on an ABI3130 Sequencer and MLPA data were evaluated using Coffalyser, a Microsoft Excel based program freely available at the MRC-Holland website.
Informed consent was received from the family.
Discussion
Bannayan-Riley-Ruvalcaba syndrome is among the rarely encountered and autosomal dominantly inherited hamartomatous polyposis syndromes. This syndrome may be diagnosed in patients with accompanying intellectual disability, macrocephaly and penile pigmentary spotting 3 , as seen in the present patient. Recognizing this combination of clinical features leads to precise genetic diagnosis and genetic counseling.
Although there is still no consensus criterion for diagnosis of BRRS, previously two reports in the literature defined a few diagnostic criteria. Marsh et al. 6 underlined that patients with BRRS have features of macrocephaly 3, 5, 9 . Epilepsy was reported in approximately 25% of patients 8, 10 . After multiple polyps were shown in colonoscopy, extra intestinal features of the present patient raised suspicion about inherited polyposis syndromes, particularly BRRS, and genetic analysis of the PTEN gene confirmed the diagnosis.
Genetic testing is required particularly when a full-blown recognizable clinical picture is absent or overlapping features are observed as there are clinical similarities and atypical presentations of polyposis syndromes. Marsh et al. 6 reported that approximately 60% of patients with BRRS are reported to have mutations in PTEN gene, which functions as a tumor suppressor gene and is located on chromosome 10q22-q23 [4] [5] [6] . Mutations in PTEN gene, controlling cellular proliferation, migration, and apoptosis, result in overgrowth syndrome and malignity (PTEN hamartoma tumor syndromes) in BRRS together with allelic CS. BRRS and CS have been insisted to be a single disorder with variability in phenotypic expression and age related penetrance. 5 Histologic features of polyps in BRRS resemble juvenile polyps 1, 3 . Gastrointestinal tract involvement was reported in 35-45% of the patients 3, 11, 12 . Polyps may be seen throughout the gastrointestinal tract but mostly in the distal ileum and colon 8 . Gastrointestinal polyps in BRRS are frequently symptomatic and may present with anemia, chronic diarrhea and small bowel invagination 4, 11 . Benign tumors of BRRS may grow rapidly and tend not to show spontaneous resolution 12 . Hence, patients presenting with juvenile polyposis should be re-evaluated for extra intestinal manifestations of BRRS and CS 3 .
Cancer screening in patients with BRRS is still not clear due to its rarity. A study about genotype-phenotype correlation of PTEN gene revealed that truncating or point mutations were associated with development of any cancer or breast fibroadenoma in BRRS 13 . Hence, a cancer screening program was scheduled for our patient as he had a complete deletion of the gene and increased risk for cancer development. Screening program should include breast, thyroid, endometrial, skin and renal cancers 4, 5, 9 .
As the risk of colon cancer development has not been defined yet, colonoscopy is accepted as a suggestion rather than a part of a definite surveillance program. Baseline screening colonoscopy for the patients with no gastrointestinal symptoms is recommended by at least age 40 and regularly after then at some centers further investigations are needed about colon cancer risks 4, 8 .
In conclusion, patients with hamartomatous polyposis should be evaluated carefully with their extra intestinal findings and family history should be questioned in search for probable inherited polyposis syndromes. Precise genetic counseling in patients with gastrointestinal juvenile polyposis requires exact genetic diagnosis and correct genetic testing.
